Search Within

Martin Fleisher

Formats
  1. Journal Article (161)
  2. Meeting Abstract (140)
  3. Book Section (6)
  4. Conference Paper (4)
  5. Book Whole (1)
Groups
  1. Department of Medicine (180)
  2. Solid Tumor Oncology Division (113)
  3. Genitourinary Oncology Service (81)
  4. Epidemiology and Biostatistics (77)
  5. Hematologic Malignancies, Division of (67)
  6. Biostatistics Service (64)

More Groups

People
  1. Howard Scher (78)
  2. Daniel Danila (48)
  3. Raymond Comenzo (36)
  4. Aseem Anand (34)
  5. Glenn Heller (32)
  6. Ping Zhou (30)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (4)

More Years

Publications
  1. Journal of Clinical Oncology (59)
  2. Clinical Chemistry (32)
  3. Blood (26)
  4. Clinical Cancer Research (10)
  5. Cancer Research (9)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. American Society of Clinical Oncology (60)
  2. American Association for Clinical Chemistry (32)
  3. American Association for Cancer Research (26)
  4. American Society of Hematology (26)
  5. Oxford University Press (19)
  6. Elsevier Inc. (16)

More Publishers

Results (312)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
    Journal Article

    Brandl, K.; Plitas, G.; Mihu, C. N.; Ubeda, C.; Jia, T.; Fleisher, M.; Schnabl, B.; DeMatteo, R. P.; Pamer, E. G.
    Nature (2008)

    Fulltext@MSK | Save
  • Circulating tumor cells in patients with castration-resistant metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Leversha, M. A.; Gonzalez-Espinoza, R.; Anand, A.; Gu, B.; Gignac, G. A.; Larson, S.; Heller, G.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • Circulating angiogenic cells in metastatic prostate cancer: Assessment of the bone marrow vascular and peripheral blood vascular compartments
    Meeting Abstract

    Seandel, M.; Fleisher, M.; Hooper, A. T.; Rafii, S.; Scher, H. I.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Calreticulin, AL-amyloidosis and high-dose melphalan
    Meeting Abstract

    Zhou, P.; Teruya-Feldstein, J.; Lu, P.; Clark, B.; Fleisher, M.; Olshen, A.; Comenzo, R. L.
    Haematologica (2007)

    Fulltext@MSK | Save
  • Analytical validation of the GeXP analyzer and identification of a gene signature biontarker for distinguishing cancer and non-cancer cell types
    Meeting Abstract

    Rai, A. J.; Anand, A.; Fleisher, M.
    Clinical Chemistry (2007)

    Fulltext@MSK | Save
  • Serum Levels of N-telopepticle (sNTX) and bone-specific alkaline phosphatase (BAP) in oncology patients (pts) who developed osteonecrosis of the jaw (ONJ) during therapy with intravenous bisphosphonates (IB)
    Meeting Abstract

    Fornier, M.; Farooki, A.; Estilo, C.; Conlin, A.; Patil, S.; Fleisher, M.; Huryn, J.; Hudis, C.
    EJC Supplements (2007)

    Fulltext@MSK | Save
  • A critique of the American(NACB) and European (EGTM) guidelines for the use of tumor markers in detection and monitoring cancer
    Meeting Abstract

    Fleisher, M.
    Tumor Biology (2007)

    Fulltext@MSK | Save
  • Evaluation of a rapid immunoassay for Busulfan quantitation in plasma
    Meeting Abstract

    Fleisher, M.; Gonzalez-Espinoza, R.; Mathews, A.; Salamone, S. J.; Courtney, J.; Harney, R. L.; He, S.; Lundell, G.
    Therapeutic Drug Monitoring (2007)

    Fulltext@MSK | Save
  • Circulating tumor cells as prognostic biomarkers in patients with metastatic prostate cancer
    Meeting Abstract

    Danila, D. C.; Heller, G.; Leversha, M. A.; Lilja, H.; Gonzalez-Espinoza, R.; Anand, A.; Larson, S.; Schwartz, L. H.; Fleisher, M.; Scher, H. I.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save